Related by context. Frequent words. (Click for all words.) 66 Adverse events 66 AEs 65 events SAEs 65 treatment emergent adverse 65 events AEs 63 dose limiting toxicities 63 laboratory abnormalities 62 thromboembolic events 61 discontinuations 60 hypersensitivity reactions 59 hepatotoxicity 59 febrile neutropenia 59 infusion reactions 59 Adverse reactions 58 myelosuppression 58 adverse reactions 58 myocardial infarctions 58 evaluable 58 discontinuations due 57 prespecified 57 RCTs 56 hypercalcemia 56 bacteremia 55 angioedema 55 exacerbations 55 intracerebral hemorrhage 55 composite endpoint 55 neutropenia 54 adalimumab 54 thrombocytopenia 54 postmarketing 54 hypotension 54 toxicities 53 mg dose 53 hypokalemia 53 thromboembolism 53 nasopharyngitis 53 evaluable patients 53 abatacept 53 patients receiving ERBITUX 53 placebo controlled trials 53 elevated liver enzymes 53 anakinra 53 limiting toxicity 52 n = 52 nonresponders 52 leukopenia 52 myocardial infarction MI 52 infliximab 52 quetiapine 52 peginterferon alfa 2a 52 Mylotarg 52 peginterferon 52 severe hypoglycemia 52 lacosamide 52 pharmacodynamic 52 mg BID 51 seroconversion 51 peripheral edema 51 HCV genotype 1 51 arthralgia 51 CDAD 51 interstitial lung disease 51 peginterferon alfa 2b 51 vicriviroc 51 TORISEL 51 ORENCIA 51 comorbid conditions 51 Discontinuation 51 myalgia 51 cSSSI 51 bosentan 51 ACTEMRA 51 renal impairment 50 raltegravir 50 intussusception 50 atazanavir 50 VAERS 50 etanercept 50 JANUVIA 50 GEMZAR 50 CIMZIA 50 ≥ 50 Secondary endpoints 50 amiodarone 50 NRTI 50 congenital anomalies 50 LVEF 50 stomatitis 50 liver toxicity 50 gastric ulcers 50 vertebral fracture 50 ceftriaxone 50 renal insufficiency 50 clinically relevant 50 mucositis 50 ARCALYST 49 PROMACTA 49 certolizumab pegol 49 statistically significant p 49 HCV infected